COVID-19: Vaccines and Therapeutics
The summit will feature conversations with medical professionals, parents and community leaders on how the medical community can encourage vaccination among pregnant people, children, teens and young adults.
With mask restrictions lifting as a new omicron variant emerges, an Allina Health infectious disease expert takes to the airwaves, encouraging people to get a first or second COVID-19 vaccine booster.
Amid new variants and lifted restrictions, an Allina Health infectious disease expert encourages…
The trial included 140 children who received the booster about 6 months after completing the primary vaccine series.
In a study of adults previously infected with COVID-19, the Pfizer and Moderna COVID-19 vaccines offered additional protection against reinfection leading to hospitalization.
The agency last week extended the J&J vaccine's shelf life and authorized two COVID-19 tests.
Experts from Duke Health explain how the COVID-19 vaccine is moving the nation toward endemicity.
The Centers for Medicare & Medicaid Services today released a memorandum and provider-specific guidance on complying with the interim final rule.
Medicare and Medicaid will cover a second Pfizer or Moderna COVID-19 booster at no cost to eligible enrollees.
HHS has stopped distributing the monoclonal antibody sotrovimab because the BA.2 omicron variant now predominates in every U.S. state and territory.
AHA has a new toolkit that hospitals and health systems can use in their communities to encourage vaccinations against influenza and COVID-19.